Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06200961 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trans-nasal Endoscopy for Bariatric Patients

Study acronym: TNE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Jun 2027 to Dec 2027
    • Study completion pushed from Dec 2027 to Jun 2028
    • Start date changed from estimate of Apr 2026 to Apr 20, 2026
    v8
  2. Start date: Dec 2025 to Apr 2026
    • Primary completion date: Dec 2026 to Jun 2027
    • Study completion date: Jun 2027 to Dec 2027
    v7
  3. Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Mar 31, 2026 to Dec 2026
    • Start date: Sep 2025 to Dec 2025
    • Study completion date: Dec 31, 2026 to Jun 2027
    • Site details revised
  4. Start date: Apr 2025 to Sep 2025
    • Trial status: Recruiting to Not Yet Recruiting
    • Primary completion date: Dec 31, 2025 to Mar 31, 2026
    • Site details revised
    v5
  5. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Start date: Oct 1, 2024 to Apr 2025
    • Primary completion date: Oct 31, 2025 to Dec 31, 2025
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Site details revised
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: May 1, 2024 to Oct 1, 2024
    • Primary completion date: May 31, 2025 to Oct 31, 2025
    • Study completion date: Jun 30, 2025 to Dec 31, 2025
    v3
  2. Start date: Feb 1, 2024 to May 1, 2024
    • Primary completion date: Jan 31, 2025 to May 31, 2025
    • Study completion date: May 31, 2025 to Jun 30, 2025
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.
Trial Details
NCT Number NCT06200961
Lead Sponsor Christopher C. Thompson, MD, MSc
Collaborators: EvoEndo, Inc.
Conditions
(from sponsor)		 Obesity, Obesity, Morbid, Obese, GI Disorders, Gastrointestinal Diseases
Related terms Digestive System Diseases, Gastrointestinal Diseases, Obesity, Obesity, Morbid
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov